Jan 25 (Reuters) – Early exploration suggesting that a popular non-psychoactive compound derived from cannabis may well assist avoid or take care of COVID-19 warrants even more investigation in rigorous clinical trials, scientists say. Several the latest laboratory scientific studies of cannabidiol, or CBD, have …